Reuters logo
BRIEF-Thrombogenics introduces new formulation of eye drug Jetrea in the US
September 28, 2017 / 4:14 PM / 3 months ago

BRIEF-Thrombogenics introduces new formulation of eye drug Jetrea in the US

Sept 28 (Reuters) - THROMBOGENICS NV:

* THROMBOGENICS NV : THROMBOGENICS SUCCESSFULLY INTRODUCES NEW ‘ALREADY-DILUTED’ FORMULATION OF JETREA® (OCRIPLASMIN) IN THE US

* NEW FORMULATION IS DESIGNED TO ELIMINATE PREPARATORY DILUTION STEPS BEFORE INJECTION

* AT POINT OF ADMINISTRATION INTO EYE ALREADY-DILUTED FORMULATION REMAIN IDENTICAL TO CURRENTLY AVAILABLE FORMULATION AFTER DILUTION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below